CINECA IRIS Institutional Research Information System

PIVA, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.774
EU - Europa 4.767
AS - Asia 4.323
SA - Sud America 590
Continente sconosciuto - Info sul continente non disponibili 387
AF - Africa 104
OC - Oceania 27
Totale 17.972
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.480
SG - Singapore 1.625
IT - Italia 1.443
CN - Cina 1.304
DE - Germania 762
BR - Brasile 457
VN - Vietnam 378
FR - Francia 368
IE - Irlanda 356
SE - Svezia 344
KR - Corea 332
UA - Ucraina 316
FI - Finlandia 259
AT - Austria 226
GB - Regno Unito 226
HK - Hong Kong 173
CA - Canada 172
IN - India 122
PL - Polonia 97
DK - Danimarca 85
JP - Giappone 75
BD - Bangladesh 69
AR - Argentina 57
ES - Italia 53
NL - Olanda 50
MX - Messico 46
ID - Indonesia 43
IQ - Iraq 34
BE - Belgio 31
SN - Senegal 31
TR - Turchia 28
CH - Svizzera 27
RU - Federazione Russa 23
AU - Australia 22
PK - Pakistan 21
EC - Ecuador 19
JM - Giamaica 19
ZA - Sudafrica 18
VE - Venezuela 15
PH - Filippine 14
RO - Romania 14
CO - Colombia 13
CZ - Repubblica Ceca 12
UZ - Uzbekistan 12
DZ - Algeria 11
GR - Grecia 11
HN - Honduras 10
BY - Bielorussia 9
CL - Cile 9
MA - Marocco 9
PR - Porto Rico 9
PT - Portogallo 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
NI - Nicaragua 8
TH - Thailandia 8
IR - Iran 7
NO - Norvegia 7
PE - Perù 7
PY - Paraguay 7
RS - Serbia 7
TW - Taiwan 7
CR - Costa Rica 6
IL - Israele 6
JO - Giordania 6
LB - Libano 6
LT - Lituania 6
SA - Arabia Saudita 6
TN - Tunisia 6
BG - Bulgaria 5
HU - Ungheria 5
KE - Kenya 5
MO - Macao, regione amministrativa speciale della Cina 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
KW - Kuwait 4
MY - Malesia 4
NP - Nepal 4
NZ - Nuova Zelanda 4
OM - Oman 4
AZ - Azerbaigian 3
EU - Europa 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MD - Moldavia 3
NG - Nigeria 3
AL - Albania 2
AM - Armenia 2
BF - Burkina Faso 2
CY - Cipro 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HR - Croazia 2
PS - Palestinian Territory 2
SV - El Salvador 2
YT - Mayotte 2
AD - Andorra 1
AG - Antigua e Barbuda 1
Totale 17.564
Salva come PNG Salva come JPEG
Città #
Singapore 909
San Jose 689
Ashburn 662
Beijing 646
Chandler 578
Santa Clara 396
Dublin 357
Torino 254
Ann Arbor 228
Jacksonville 214
Houston 209
Dallas 195
Fairfield 192
Milan 180
Turin 180
Vienna 171
Hong Kong 153
The Dalles 140
Los Angeles 137
Villeurbanne 130
Nyköping 129
Wilmington 127
Council Bluffs 122
Columbus 113
Ho Chi Minh City 112
Princeton 106
Lauterbourg 105
Medford 102
New York 98
Seoul 95
Woodbridge 94
Warsaw 92
Dearborn 86
Hefei 84
Boston 82
Hanoi 82
Buffalo 81
Munich 79
Rome 69
Cambridge 64
Shanghai 60
Seattle 55
Redwood City 53
Boardman 49
Pisa 49
Fremont 48
São Paulo 44
Dong Ket 41
Verona 39
Guangzhou 38
Tokyo 38
Helsinki 35
Orem 34
Chicago 33
Turku 33
Toronto 32
Novara 31
Jakarta 28
Phoenix 28
Bologna 27
Frankfurt am Main 27
Hangzhou 27
Ottawa 26
Nanjing 25
Bengaluru 24
Brooklyn 24
Brussels 24
Düsseldorf 23
Nuremberg 22
London 21
Chennai 20
Da Nang 20
Montreal 19
Philadelphia 19
Madrid 18
Naples 18
San Francisco 18
San Mateo 18
Washington 17
Cleveland 16
Lappeenranta 16
Norwalk 16
Denver 15
Memphis 15
Baghdad 14
Mumbai 14
Pune 14
San Diego 14
Amsterdam 13
Atlanta 13
Jinan 13
Lachine 13
Miami 13
Paris 13
Stockholm 13
Xian 13
Birmingham 12
Curitiba 12
Manchester 12
Mexico City 12
Totale 10.033
Salva come PNG Salva come JPEG
Nome #
PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas. 691
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies 533
Mutations in NOTCH1 PEST-domain orchestrate CCL19-driven homing of Chronic Lymphocytic Leukemia cells by modulating the tumor suppressor gene DUSP22 515
PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma. 507
p130Cas mediates the transforming properties of the anaplastic lymphoma kinase 316
The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. 311
Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma. 301
The RNA-binding protein ESRP1 promotes human colorectal cancer progression 296
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p 296
STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK positive anaplastic large cell lymphoma. 286
Identification of a new subclass of ALK negative ALCL expressing aberrant levels of ERBB4 transcripts 272
ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma 259
IRF4 Mediates the Oncogenic Effects of STAT3 in Anaplastic Large Cell Lymphomas 253
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma 235
SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response 231
Anaplastic lymphoma kinase in human cancer 217
Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma 210
Nampt over-expression recapitulates the braf inhibitor resistant phenotype plasticity in melanoma 208
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation 207
The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma 207
Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma 200
BRAF-mediated NAMPT overexpression induces a melanoma cell dedifferentiation program leading to metabolic reprogramming and intrinsic resistant to BRAF inhibitors 198
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death 197
ALK expression favorably impacts the prognosis of NRAS-mutated metastatic melanomas 192
Anaplastic large-cell lymphoma 188
The heterogeneous landscape of ALK negative ALCL 185
bcl-2 protein expression in aged brain and neurodegenerative diseases. 183
ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis 177
p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity 176
Ablation of oncogenic ALK is a viable therapeutic approach fAblation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas 172
Mutations in NOTCH1 PEST Domain Orchestrate CCL19-Driven Homing of Chronic Lymphocytic Leukemia (CLL) Cells By Modulating the Gene DUSP22 169
Genomic and functional approaches as powerful tools to stratify human T-cell lymphoproliferative disorders and to identify relevant tumorigenic culprits 164
Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension 164
15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-kappa B activity and down-regulation of antiapoptotic proteins 162
Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines 161
MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma 161
CD30 expression in anaplastic large cell lymphomas is dependent on ALK tyrosine kinase activity via Stat3 phosphorylation and JunB upregulation 157
A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities 152
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma 145
c-Jun, JNK/SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis. 145
Wild-type idh enzymes as actionable targets for cancer therapy 141
A cell cycle alteration precedes apoptosis of granule cell precursors in the weaver mouse cerebellum. 140
Activated p38MAPK is a novel component of the intracellular inclusions found in human amyotrophic lateral sclerosis and mutant SOD1 transgenic mice 139
Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes 139
Dissection of critical pathways instrumental to the Anaplastic Lymphoma Kinase oncogenic activity 138
Unveiling the pathogenetic role of Stat3 in human lymphoma 137
Nuclear Akt2 opposes limbal keratinocyte stem cell self-renewal by repressing a FOXO-mTORC1 signaling pathway. 137
Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis. 137
Molecular anatomy of peripheral T cell lymphomas 136
Transposable elements: The enemies within 136
Dissection of critical pathways instrumental for Anaplastic Lymphoma Kinase transformation 134
Next Generation Sequencing (NGS) Strategies for Genetic Testing of Cerebral Cavernous Malformation (CCM) Disease 134
Identification of genomic and proteomic signatures in lymphomas by inducible shRNA 132
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins 130
Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma? 130
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. 128
S-100beta protein is upregulated in astrocytes and motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis. 126
Identification of molecular classifiers and key signalling networks in T-cell lymphoproliferative disorders through gene expression profiling meta-analyses 126
Hypermethylation-Mediated Silencing of CIDEA, MAL and PCDH17 Tumour Suppressor Genes in Canine DLBCL: From Multi-Omics Analyses to Mechanistic Studies 126
The anaplastic lymphoma kinase in the pathogenesis of cancer 125
Lynch syndrome-associated endometrial cancer patient with a rare novel germline likely pathogenic variant of MSH2 gene: A case report 122
Targeting oncogenic ALK by stable small interfering RNA induces cell death of human Anaplastic Large Cell Lymphoma cells 121
Identification and validation of the anaplastic large cell lymphoma signature 120
CEP-18770: a novel orally-active proteasome inhibitor with a tumor-selective pharmacological profile competitive with bortezomib 119
S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase 118
Network-based inference of tumorogenic culprits in human T-cell lymphoproliferative disorders 116
CDKN2/p16 inactivation and p16 immunohistochemistry in astrocytic gliomas. 115
Biomimetic mesoporous vectors enabling the efficient inhibition of wild-type isocitrate dehydrogenase in multiple myeloma cells 114
p27/kip1 expression in oligodendrogliomas and its possible prognostic role. 114
The landscape of signaling pathways and proteasome inhibitors combinations in multiple myeloma 110
Gene Expression Profiling Uncovers Molecular Classifiers for theRecognition of Anaplastic Large-Cell Lymphoma Within Peripheral T-Cell Neoplasms 109
Targeting oncogenic ALK by lentiviral small interfering RNA induces growth arrest and apoptosis of human anaplastic large cell lymphoma cells 108
In situ hybridization analysis of Girk2 expression in the developing central nervous system in normal and weaver mice. 107
Essential role of PDK1 in regulating endothelial cell migration 106
IL-6, but not IFN-gamma, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing 105
Network-based inference of ALK oncogenic signaling in T-cell lymphoproliferative disorders 105
p27/Kip.1 ubiquitin ligase subunit skp2 relationships with cell proliferation and p27/Kip.1 expression in gliomas 105
The expression signature of Anaplastic Large Cell Lymphomas: from cell line to primary tumors 104
Gene expression profiling uncovers molecular classifiers for the recognition of Anaplastic Large Cell Lymphoma within Peripheral T-cell neoplasms 103
Cell-cycle inhibitor p27/Kip-1 expression in non-astrocytic and non-oligodendrocytic human nervous system tumors. 102
Role of apoptosis in the prognosis of oligodendrogliomas 101
Genomic instability in multiple myeloma: A “non‐coding rna” perspective 97
Expression of angiopoietin-1 in human glioblastomas regulates tumor-induced angiogenesis: in vivo and in vitro studies. 95
In vivo interference with Skp1 function leads to genetic instability and neoplastic transformation. 95
Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myeloma 93
Extraction Bottleneck in the Diagnosis of SARS-CoV-2: Evaluation of an Alternative Protocol Derived from Veterinary Use 92
Cyclin D1 expression in gliomas 92
Targeting oncogenic ALK by lentiviral small interfering RNA induces growth arrest and apoptosis of human Anaplastic Large Cell Lymphoma cells 90
Isolation and characterization of sphere-forming cells from a gliosarcoma patient 90
Proteasome-dependent degradation of p27/kip1 in gliomas. 89
Molecular events underlying interleukin-6 independence in a subclone of the CMA-03 multiple myeloma cell line. 89
Specific Induction of Akt3 in Spinal Cord Motor Neurons is Neuroprotective in a Mouse Model of Familial Amyotrophic Lateral Sclerosis. 88
Three-gene diagnostic classifier for ALK negative ALCL 86
UBE2I mutations unveil the critical role of the SUMOylation pathway in syndromic autism 86
Characterization of murine Girk2 transcript isoforms: structure and differential expression. 86
Inverse relationship between p27/Kip.1 and the F-box protein Skp2 in human astrocytic gliomas by immunohistochemistry and Western blot. 86
NF-kappaB: a stress-regulated switch for cell survival 83
Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma 82
UBE2I mutations unveil the critical role of the SUMOylation pathway in syndromic autism 81
Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway 81
Totale 16.475
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.332
article - articoli 0
book - libri 0
conference - conferenze 8.548
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.880
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.051 0 0 46 111 53 46 60 53 36 117 293 236
2022/20231.721 187 178 40 178 138 426 118 77 206 42 76 55
2023/2024846 114 138 43 28 57 134 32 62 14 43 68 113
2024/20252.564 30 166 106 223 491 120 137 143 300 194 262 392
2025/20265.522 555 297 422 621 525 231 811 163 384 390 382 741
2026/2027996 303 491 202 0 0 0 0 0 0 0 0 0
Totale 17.972